Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia

Charles H. Adler, Stewart A. Factor, Mitchell Brin, Kapil Dev Sethi

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Intramuscular injection of botulinum toxin type A is the treatment of choice for most cases of oromandibular dystonia. We report on five patients with oromandibular dystonia that developed secondary nonresponsiveness to botulinum toxin type A following multiple injections over a 6-year period.

Original languageEnglish (US)
Pages (from-to)158-161
Number of pages4
JournalMovement Disorders
Volume17
Issue number1
DOIs
StatePublished - Jan 1 2002

Keywords

  • Botulinum toxin
  • Immunoresistance
  • Oromandibular dystonia

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia'. Together they form a unique fingerprint.

  • Cite this